JPRN-C000000340已完成2 期
Effects of phosphodiesterase V (sildenafil) on pulmonary arterial hypertension - Effects of sildenafil on pulmonary arterial hypertension
Division of cardiovascular internal medicine, The University of Tokyo Hospital0 个研究点目标入组 20 人开始时间: 2006年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with PCWP>15mmHg 2. Pregnat women or women of childbearing potential or brestfeeding 3. Patients who are being treated with medicines that contain nitrates 4. Patients who are being treated with phosphodiesterase inhibitors other than sildenafil 5. Patients who are otherwise judged inappropriate for inclusion in the study by the investigators
研究者
相似试验
Unknown
2 期
Sildenafil in Hemodialysis Patients With Pulmonary HypertensionHemodialysis ComplicationPulmonary HypertensionNCT03763045Ain Shams University60
撤回
不适用
Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary HypertensionPrimary and Secondary Pulmonary HypertensionNCT00155714National Taiwan University Hospital20
撤回
不适用
The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder PatientsMajor Depressive DisorderNCT04344678Sadat City University100
已完成
2 期
Sildenafil for Treatment of Priapism in Men With Sickle Cell AnemiaSickle Cell DiseasePriapismNCT00940901Johns Hopkins University13
招募中
2 期
The effects of sildenaphil on oligohydramniosOligohydramnios.OligohydramniosIRCT20091023002624N21Iran University of Medical Sciences190